BluGlass Ltd of Silverwater, Australia — which develops and manufactures gallium nitride (GaN) blue laser diodes based on its proprietary low-temperature, low-hydrogen remote-plasma chemical vapor deposition (RPCVD) technology — has secured an AUS$1.2m order for the first phase (lasting about 12-months) of a three-phase joint development agreement (JDA) with Uviquity of Raleigh, NC, USA, a venture-backed start-up pioneering wide-bandgap integrated photonics.
The multi-year development agreement will see BluGlass and its collaboration partner develop novel photonic chips that combine highly complementary technologies for the production of Heterogeneously Integrated Photonic Integrated Circuits (HIPIC).
Jim Haden, BluGlass CEO, said, “This agreement leverages BluGlass’ core epitaxy, wafer fabrication, custom device capabilities, and our ability to solve our customers’ greatest challenges. This JDA is a testament to our talented team and technological capabilities. BluGlass and Uviquity are joining forces to pioneer next-generation integrated photonics. We are excited to collaborate with Uviquity’s talented team, to bring their innovative products to market.”
Scott Burroughs, CEO of Uviquity, said, ”BluGlass has developed leading blue semiconductor laser technology and production capabilities that enhance our next generation wide bandgap photonic integrated circuits. That combination makes BluGlass an ideal partner, and we are delighted to work with their exceptional team.”
The multi-phase, potentially three-year Joint Development Agreement has the potential for a minimum of two additional phases of non-recurring engineering, each with a similar revenue potential for BluGlass. The parties agree to execute a follow-on Master Supply Agreement to produce the HIPIC devices, six months before the completion of the development phases, with significant commercial potential.